Stock research
Copart, Inc. CPRT
Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.
- Ticker
- CPRT
- Exchange
- NASDAQ
- Sector
- Industrials
- Founded
- —
What moves CPRT
Copart, Inc. sits in Industrials. Aerospace, machinery, defense, and transports — a cyclical read on capex, reshoring, and the physical economy. The forces that matter most for the sector — and therefore for CPRT — are:
- ◆Capital-spending and manufacturing PMIs
- ◆Reshoring and supply-chain reconfiguration
- ◆Defense budgets and geopolitical conflict
- ◆Freight rates and logistics demand
Congressional trading in CPRT
No matched CPRT transaction appears in the current verified House Clerk snapshot. We do not turn a missing row into a claim that no member has ever traded the security.
Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.
The profile is free
CPRT research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.
Profiles related to Industrials
How Yield Theory covers CPRT
CPRT intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.
More Industrials stocks
CPRT — frequently asked questions
What sector is CPRT in?
Copart, Inc. is classified in the Industrials sector and trades on the NASDAQ.
Do members of Congress trade CPRT?
The current verified House Clerk snapshot contains no matched CPRT transaction rows. That is not proof that no lawmaker has ever traded the security.
Is CPRT a good investment?
We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
See whether the CPRT thesis still holds.
This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included